These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 688256)

  • 1. cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung.
    Britell JC; Eagan RT; Ingle JN; Creagen ET; Rubin J; Frytak S
    Cancer Treat Rep; 1978 Aug; 62(8):1207-10. PubMed ID: 688256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adriamycin-cyclophosphamide and adriamycin-cis-dichloro-diammineplatinum(II) combination chemotherapy in patients with advanced cancer.
    Higby DJ; Wilbur D; Wallace HJ; Henderson ES; Weiss R
    Cancer Treat Rep; 1977 Aug; 61(5):869-73. PubMed ID: 329980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II) in patients with advanced adenocarcinoma of the lung.
    Eagan RT; Frytak S; Ingle JN; Creagan ET; Nichols WC; Kvols LK
    Cancer Treat Rep; 1980; 64(8-9):925-8. PubMed ID: 7192602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study in advanced sarcoma: randomized trial of pyrazofurin versus combination cyclophosphamide, doxorubicin, and cis-dichlorodiammineplatinum(II) (CAP).
    Cormier WJ; Hahn RG; Edmonson JH; Eagan RT
    Cancer Treat Rep; 1980; 64(4-5):655-8. PubMed ID: 7191779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy for ovarian carcinoma with cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) after failure of initial chemotherapy.
    Bruckner HW; Ratner LH; Cohen CJ; Wallach R; Kabakow B; Greenspan EM; Holland JF
    Cancer Treat Rep; 1978 Jul; 62(7):1021-3. PubMed ID: 688244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung].
    Sanz Ortiz J; Saiz García F
    Med Clin (Barc); 1982 Nov 16-30; 79(9):403-6. PubMed ID: 6296560
    [No Abstract]   [Full Text] [Related]  

  • 8. Adriamycin and cis-dichlorodiammineplatinum in nonresectable and metastatic carcinoma of the lung.
    Morris RW; Brubaker LH; Kardinal CG; Carolla RL; Perry MC
    Cancer Clin Trials; 1979; 2(1):37-41. PubMed ID: 229982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination cyclophosphamide, doxorubicin, and cisplatin (CAP) chemotherapy for extensive non-small cell carcinomas of the lung.
    Davis S; Rambotti P; Park YK
    Cancer Treat Rep; 1981; 65(11-12):955-8. PubMed ID: 7028257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy with adriamycin (NSC-123127) and cyclophosphamide (NSC-26271) for solid tumors: a phase II trial.
    Lloyd RE; Jones SE; Salmon SE; Durie BG; McMahon LJ
    Cancer Treat Rep; 1976 Jan; 60(1):77-83. PubMed ID: 1000520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ovarian adenocarcinoma stage III and IV treated by a combination of adriamycin, cyclophosphamide, 5-fluorouracil and cis-DDP. Therapeutic role of cis-DDP in this combination].
    Pouillart P; Bretaudeau B; Palangie T; Jouve M; Garcia-Giralt E; Asselain B
    Bull Cancer; 1982; 69(5):434-42. PubMed ID: 6891903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date.
    Harper P
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-23-S15-25. PubMed ID: 9346217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of clinical therapeutic synergism between cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) in metastatic human colorectal carcinoma.
    O'Connell MJ; Moertel CG; Rubin J; Schutt AJ; Creagan ET
    Cancer Treat Rep; 1980; 64(2-3):311-3. PubMed ID: 7190870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination chemotherapy with cyclophosphamide, adriamycin, cisplatin, nimustine, and methotrexate (EACAM) in advanced adenocarcinoma of the lung].
    Nakanishi F; Mogi H; Sugiishi M; Sugiura I; Ogasawara T; Kinoshita T; Hoshino A
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3413-8. PubMed ID: 3466573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two sequential studies for primary peritoneal carcinoma: induction with weekly cisplatin followed by either cisplatin-doxorubicin-cyclophosphamide or paclitaxel-cisplatin.
    Piver MS; Eltabbakh GH; Hempling RE; Recio FO; Blumenson LE
    Gynecol Oncol; 1997 Nov; 67(2):141-6. PubMed ID: 9367697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lung.
    Edmonson JH; Lagakos SW; Selawry OS; Perlia CP; Bennett JM; Muggia FM; Wampler G; Brodovsky HS; Horton J; Colsky J; Mansour EG; Creech R; Stolbach L; Greenspan EM; Levitt M; Israel L; Ezdinli EZ; Carbone PP
    Cancer Treat Rep; 1976 Jul; 60(7):925-32. PubMed ID: 1009523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination chemotherapy using cyclophosphamide, adriamycin, and cisplatin in recurrent or advanced endometrial cancer--a preliminary report].
    Baba S; Kashimura M; Shinohara M; Kusano S; Sasayama T; Hamasaki K
    Gan No Rinsho; 1989 Feb; 35(3):371-7. PubMed ID: 2926985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination chemotherapy with cyclophosphamide, adriamycin, cisplatin, nimustine(ACNU), and methotrexate (EACAM) in advanced adenocarcinoma of the lung].
    Nakanishi F; Sugiishi M; Ogasawara T; Sugiura I; Kinoshita T; Ito Y; Hoshino A
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1339-44. PubMed ID: 3859252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma.
    Evans WK; Feld R; DeBoer G; Osoba D; Curtis JE; Baker MA; Myers RE; Quirt IC; Pritchard KI; Brown TC; Kutas GJ; Blackstein ME; Ottema B; Millband L
    Cancer Treat Rep; 1981; 65(11-12):947-54. PubMed ID: 7028256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cis-Dichlorodiammineplatinum(II), adriamycin, cyclophosphamide, CCNU, and vincristine in non-small cell lung carcinoma: a preliminary report.
    Takita H; Marabella PC; Edgerton F; Rizzo D
    Cancer Treat Rep; 1979 Jan; 63(1):29-33. PubMed ID: 369692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.